QIBA for Statisticians: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 14: | Line 14: | ||
Statisticians | Statisticians '''may also''': | ||
* | * optimize study design in clinical trials with QIBs | ||
* | * determine sample size calculations for clinical trials using QIBs | ||
* | * provide unbiased estimates of treatment effects when QIBs are endpoints | ||
Revision as of 20:01, 17 September 2019
QIBA Mission: Improve the value and practicality of quantitative imaging biomarkers by reducing variability across devices, sites, patients, and time.
QIBA develops Profile documents that standardize methods for creating a specific biomarker with predictable performance (accuracy and reproducibility).
Statisticians benefit from QIBA by:
- understanding the role of technical performance characteristics (repeatability, reproducibility, bias, linearity) in the study design and analysis of clinical trials with quantitative imaging biomarkers (QIBs)
- understanding the role of technical performance characteristics in quantifying change in individual patients
- (being provided with good estimates of the technical performance of QIBs obtained using a given QIBA Profile)
Statisticians participate in QIBA Profiles by:
- supporting testing of actors’ conformance with requirements in a given QIBA Profile
Statisticians may also:
- optimize study design in clinical trials with QIBs
- determine sample size calculations for clinical trials using QIBs
- provide unbiased estimates of treatment effects when QIBs are endpoints